๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Natural History and Treatment of Hepatitis C in Liver Transplant Recipients

โœ Scribed by Kimberly A. Brown


Book ID
107540519
Publisher
Current Science Inc.
Year
2010
Tongue
English
Weight
223 KB
Volume
9
Category
Article
ISSN
1540-3416

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Treatment of hepatitis C in liver transp
โœ Fredric D. Gordon; Paul Kwo; Hugo E. Vargas ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 182 KB ๐Ÿ‘ 1 views

Recurrent hepatitis C after liver transplantation is a universal phenomenon. Graft reinfection occurs rapidly; once it is established, allograft cirrhosis and decompensation rapidly ensue in many patients. Treatment with pegylated interferon plus ribavirin is the standard of care among nontransplant

The natural history of hepatitis C virus
โœ Neal R. Barshes; Ian W. Udell; Timothy C. Lee; Christine A. O'Mahony; Saul J. Ka ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 159 KB ๐Ÿ‘ 1 views

Although rare in the pediatric population, the natural history of hepatitis C virus (HCV) recurrence in pediatric patients undergoing orthotopic liver transplantation (OLT) for end-stage liver disease secondary to HCV has not been well described. We performed an analysis of all 67 pediatric patients

Rimantadine for treatment of hepatitis C
โœ Sherman, Kenneth E. ;Sickler, Joelle ;Aranda-Michel, Jaime ;Weber, Frederick L. ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› Wiley (John Wiley & Sons) ๐ŸŒ English โš– 61 KB ๐Ÿ‘ 2 views

Hepatitis C recurrence after liver transplantation is a serious problem, leading to increased graft loss and morbidity in some individuals. Treatment with interferon and other agents is controversial and not highly efficacious. The use of an effective antiviral agent to reduce or eliminate viral bur

Treating hepatitis C infection in liver
โœ Norah A. Terrault; Marina Berenguer ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 192 KB ๐Ÿ‘ 1 views

Chronic infection with hepatitis C virus (HCV) is a growing problem worldwide, with up to 300 million individuals infected, and those with chronic infection are at risk for cirrhosis and hepatocellular carcinoma. HCV infection is the most common indication for liver transplantation in the United Sta